Squarepoint’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5M | Buy |
416,572
+271,005
| +186% | +$7.5M | 0.01% | 521 |
|
|
2025
Q1 | $3.23M | Buy |
145,567
+118,759
| +443% | +$2.64M | ﹤0.01% | 941 |
|
|
2024
Q4 | $530K | Buy |
+26,808
| New | +$530K | ﹤0.01% | 1910 |
|
|
2024
Q3 | – | Sell |
-24,845
| Closed | -$464K | – | 2786 |
|
|
2024
Q2 | $464K | Buy |
24,845
+11,344
| +84% | +$212K | ﹤0.01% | 1764 |
|
|
2024
Q1 | $266K | Sell |
13,501
-9,267
| -41% | -$183K | ﹤0.01% | 1970 |
|
|
2023
Q4 | $399K | Sell |
22,768
-24,731
| -52% | -$434K | ﹤0.01% | 1822 |
|
|
2023
Q3 | $825K | Sell |
47,499
-2,975
| -6% | -$51.7K | ﹤0.01% | 1398 |
|
|
2023
Q2 | $711K | Buy |
50,474
+30,929
| +158% | +$435K | ﹤0.01% | 1443 |
|
|
2023
Q1 | $210K | Buy |
19,545
+7,382
| +61% | +$79.4K | ﹤0.01% | 1850 |
|
|
2022
Q4 | $182K | Buy |
+12,163
| New | +$182K | ﹤0.01% | 1917 |
|
|
2021
Q3 | – | Sell |
-28,744
| Closed | -$400K | – | 2503 |
|
|
2021
Q2 | $400K | Buy |
+28,744
| New | +$400K | ﹤0.01% | 1759 |
|
|
2021
Q1 | – | Sell |
-53,075
| Closed | -$938K | – | 2802 |
|
|
2020
Q4 | $938K | Buy |
53,075
+15,484
| +41% | +$274K | 0.01% | 1121 |
|
|
2020
Q3 | $576K | Buy |
37,591
+14,559
| +63% | +$223K | 0.01% | 1252 |
|
|
2020
Q2 | $587K | Buy |
23,032
+12,633
| +121% | +$322K | 0.01% | 1211 |
|
|
2020
Q1 | $161K | Sell |
10,399
-110,423
| -91% | -$1.71M | ﹤0.01% | 1535 |
|
|
2019
Q4 | $1.34M | Buy |
120,822
+91,926
| +318% | +$1.02M | 0.01% | 1133 |
|
|
2019
Q3 | $246K | Sell |
28,896
-9,504
| -25% | -$80.9K | ﹤0.01% | 1898 |
|
|
2019
Q2 | $520K | Buy |
38,400
+11,860
| +45% | +$161K | 0.01% | 1603 |
|
|
2019
Q1 | $479K | Buy |
26,540
+11,788
| +80% | +$213K | 0.01% | 1482 |
|
|
2018
Q4 | $414K | Buy |
14,752
+2,223
| +18% | +$62.4K | ﹤0.01% | 1336 |
|
|
2018
Q3 | $319K | Buy |
+12,529
| New | +$319K | ﹤0.01% | 1507 |
|